News Releases

Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy Read More

Restore Vision Secures JPY 1.3 Billion in Pre-Series B Financing, Bringing Total Funding to More Than JPY 5.8 Billion Including Grants Read More